"Surveillance-based business models pose all kinds of problems...
Category:
Eco/Invest/Demography
Latest
US says to investigate national security data risks from Chinese vehicles
"China's policies could flood our market with its vehicles, posing...
SC upholds Rajasthan’s 2-child norm for govt jobs
“This court held that the classification, which disqualifies...
SC refuses to entertain plea for national policy for compensation to COVID-19 victims
A bench of Justices Ashok Bhushan and R S Reddy dismissed the plea saying that every state has a different policy and gives compensation as per its financial power.
Advocate Deepak Prakash, appearing for petitioner Hashik Thayikandy, said that all he is asking for is a national policy to be formulated that would provide for uniform compensation throughout the country.
India’s coronavirus cases surge to 3.1 million
The number of deaths in the last 24 hours was 836, taking the total to 57,542.
While Mumbai and Delhi still figure in the top three cities in the number of cases, the total share of the top 10 districts has dropped from around 60 per cent to around 33.5 per cent
Validity of motor vehicle documents extended till Dec 30
On March 30, the ministry had announced the extension of the validity of fitness, permit (all types), driving license, registration or any other concerned document till June 30.
Later on June 9, the validity of motor vehicle documents was further extended till September 30 due to the pandemic.
Bears are going extinct in US stock market’s $13 trillion rebound
“It looks like all those fund managers over the past quarter went from being bearish and expecting a stock market crash to now bullish,” Shawn Cruz, senior market strategist at TD Ameritrade, said in an interview. “Sentiment’s turned positive about equities in general but also sentiment is turning positive for a return to growth.”
The tide is getting harder to fight with retail investors flocking to unprofitable companies such as Nikola Corp. and Moderna Inc. More money managers are forced to embrace the rally, ignoring this year’s profit contraction and banking on fiscal and monetary stimulus. At 26 times forecast earnings, the S&P 500 was trading at the highest multiple since the dot-com era.
Europe’s Covid surge looks less deadly as rise in testing keep deaths low
Many of the infections stem from younger people traveling and partying during the summer holidays, and some of those cases have been asymptomatic. Better treatment of the disease and improved procedures for identifying Covid-related deaths also help lower the death toll, John Ford, a lecturer in public health at the University of Cambridge.said.
Global coronavirus deaths exceed 800,000
The rate of deaths is holding steady with it taking 17 days to go from 700,000 to 800,000 deaths — the same time it took to go from 600,000 to 700,000.
The U.S. death toll surpassed 170,000 on Sunday, the highest in the world. While the number of new cases is down from a peak in July, the country is still seeing over 360,000 new cases a week.
WHO says children aged 12 and over should wear masks like adults
Studies suggest older children potentially play a more active role in transmission of the new coronavirus than younger children, the WHO and UNICEF said, adding more data was needed to better understand the role of children and adolescents in the transmission of the virus, which causes COVID-19.
The WHO first advised people to wear masks in public on June 5 to help reduce the spread of the disease, but had previously not issued specific guidance for children.
412 infra projects show cost overruns of Rs 4.11 lakh crore
“Total original cost of implementation of the 1,683 projects was Rs 20,65,336.20 crore and their anticipated completion cost is likely to be Rs 24,77,167.67 crore, which reflects overall cost overruns of Rs 4,11,831.47 crore (19.94 per cent of original cost),” the ministry”s latest report for June 2020 said.
New antibody tests offer a better snapshot of coronavirus immunity
Antibodies are markers of infection, and testing for them helps health officials see how widely the virus has spread. Until now, most tests could tell only whether they’re present. The newer ones go a step further, measuring the quantity of these proteins, which are raised by the immune system to disable viral invaders.
Covishield vaccine to be sold only after successful trial: Serum Institute
SII issued this clarification after reports in the media began appearing which claimed that Covishield- Oxford University’s vaccine candidate, will be commercialised in a little over two months.
The phase three trials for the Oxford vaccine candidate are being conducted by SII in India.
Serum Institute of India clarifies that the current claims over Covishield’s availability, in the media are completely false and conjectural. Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use,” SII said.